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Figure 1.  (A) Types of photoreceptors (a) rod; (b) cone. (B) Scanning electron micrograph of 
the rods and cones of the primate retina (from Webvision).  
Figure 3. Fundoscopy of the 
phenotype observed in the family. (a, 
b) 30 years-old patient (III:8): slight 
pallor of the optic disc, normal retinal 
vessels, atrophy of retinal pigment 
epithelium (RPE) in the macula with 
pigment dispersion and scattered 
pigment deposits; (c, d) 23 year-old 
patient (III:5): normal optic disc, 
normal retinal vessels, atrophy of RPE 
in the macula area; (e) normal fundus. 
  
Table 1. Visual acuity of the affected members of the family. VOD, VOS: visual acuity 
right and left eye, respectively; ERG: electroretinogram; LP: light perception; HM: 
hand motion; CF: count fingers; NR: nonrecordable; ND: nondetectable. 
A 
Figure 2. Gypsy family with adCORD. (A) Family tree with haplotypes 
spanning the linked interval on chromosome 10. Asterisks mark individuals 
who were clinically examined; Filled symbols: affected individuals; symbols 
with diagonal slash: deceased members; black vertical bars: haplotype 
segregating with the disease in the family. (B) LOD score diagram generated 
by GENEHUNTER 
B 
Figure 4.  Schematic representation of the total genome 
analysis using 10K SNP array generated by the 
GENEHUNTER software. The genetic interval (cM)/each 
chromosome (1-23) on the x axis is plotted against the 
LOD score on the y axis. The higher and the greater the 
width of the red peak the more likely it is to represent the 
true locus for linkage. One clear peak, indicated by arrow, 
is visible on chromosome 10 with a genome-wide 
significant LOD score of 3.31 
PURPOSE 
To map a novel locus for adCORD and to identify the disease causing gene using a three-generation family 
of Gypsy origin. 
MATERIAL AND METHODS 
Subjects. Full ophthalmological examination was performed on 15 family members (Fig. 2A) using corrected 
visual acuity, direct and indirect ophthalmoscopy, colour fundus photography and full-field electroretinography 
(ERG). 
Whole Genome Scan. Multiplex STR genotyping was performed using 460 fluorescently labelled STR 
markers (ABI PRISM ® Linkage Mapping Sets V2.5). DNA samples were also genotyped by total genome-
sampling analysis using the GeneChip® Human Mapping 10K Array Xba142 2.0 (Affymetrix). 
Linkage analysis. Alleles were assigned to individuals and genotypic data used to calculate the LOD scores 
using both two-point and parametric multipoint linkage analysis, MLINK and GENEHUNTER software, 
respectively. The phenotype was analyzed as an autosomal dominant trait with complete penetrance (0.9990) 
and a frequency of 0.0001 for the affected allele.  
Mutation screening. Sequencing analysis was performed using BigDye® Terminator v3.1 Cycle Sequencing 
kit (Applied Biosystems) and the ABI® 3730xl Genetic Analyzer. 
Comparative Genomic Hybrizidation (CGH). This technology was applied to search for unreported CNVs in 
the whole genome first and next on Chromosome 10 specifically (Human CGH 385K Whole-Genome Tiling 
array and Chromosome 10 tiling aCGH, respectively (NimbleGen)).  
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CONCLUSIONS  
1. By obtaining a LOD score higher than 3 for more than one STR and SNP markers spanning a 7.2 Mb-interval 
on chromosome 10 we provide significant evidence for a new adCORD locus in the human genome. 
2. Several interesting candidate genes map to this interval but no pathological changes were found. 
3. Based on the data, this tentatively defines a novel locus in the human genome which is the only locus for 
adCORD known to map to this region. 
4. Based on genotype-phenotype correlation study incomplete penetrance or variable expression of adCORD 
could also be considered for this family.  
Table 2. Microsatellite (STR) markers for the 12 known 
genes/loci reported to be associated with 
adCOD/adCORD. Two-point LOD score analysis was 
done using the MLINK software  
Genes and loci 
Gene location/ 
position (Mb)/  
size (Kb) 
 
STRs 
 
STRs  position (Mb) 
 
LOD score (θ=0) 
1. AIPL1 17p13.2/ 
6.32-6.33/ 
11.46 
D17S938 6.24 - 6.20 
D17S1852 10.51 - 6.52 
2. CRX  19q13.32/ 
48.62-48.34/  
21.48 
D19S903 45.04 - 0.03 
D19S902 48.33 - 6.02 
D19S904 50.77 0.06 
3. GUCA1A 6p21.1/  
42.12-42.14/  
24.65 
D6S1610 39.25 - 1.07 
D6S1549 41.38 0.54 
4. GUCY2D  17p13.1/  
7.90-7.93/  
17.67 
D17S938 6.24 - 6.20 
D17S1852 10.51 - 6.52 
5. PITPNM3  17p13.2/  
6.35-6.45/  
105.29 
D17S938 6.24 - 6.20 
D17S1852 10.51 - 6.52 
6. PROM1  4p15.32/  
15.96-16.08/  
121.30 
D4S403 13.75 - 1.86 
7. PRPH2 6p21.2/  
42.66-42.69/  
25.97 
D6S1610 39.25 - 1.07 
D6S1549 41.38 0.54 
D6S1650 44.13 - 6.25 
8. RIMS1  6q13/ 
72.59-73.11/ 
516.43 
D6S455 71.51 - 7.68 
D6S421 72.07 - 6.25 
D6S1681 72.21 - 6.72 
9. SEMA4A 1q22/ 
156.11-156.14/ 
30.38 
D1S498 151.30 - 0.34 
D1S2635 159.17 - 5.73 
10. UNC119  17q11.2/ 
26.873-26.879/ 
5.9 
D17S1824 26.66 - 6.47 
11. CORD4 17q/ 
25.70-81.02/ 
55.40 
D17S1824 26.66 - 6.47 
D17S927 35.00 - 5.82 
D17S1868 47.18 - 6.80 
D17S787 53.28 - 0.44 
D17S944 61.43 - 7.17 
D17S785 74.43 - 8.47 
D17S784 77.80 - 6.14 
D17S928 80.25 - 1.02 
12. RCD1 6q25-q26 D6S309 8.22 - 0.67 
D6S470 10.02 - 0.63 
RESULTS 
Clinical examination. Six family members were found to be affected (age range between 23-70 years) and nine 
were completely normal (Fig.2A). Visual acuity of the affected individuals is listed in Table 1. Ophthalmoscopy 
revealed normal retinal vessels and optic disc in the youngest affected members (Fig.3) which progress to 
attenuated retinal vessels and optic disk pallor in both of the oldest patients (64 and 70 years). Atrophic patches 
in the pigmented epithelium with scattered pigment deposits in the macular area extending to the midperiphery 
were found in all patients (image not shown).  
Genotyping and linkage analysis. All previously known loci for adCORD were excluded using STR markers 
(Table 2). A genome wide scan using STR markers was performed allowing the exclusion of all regions, except a 
7.2-Mb interval on chromosome 10 (Fig.2B), also confirmed by a second independent total genome scan 
performed using the GeneChip Human Mapping 10K Array Xba142 2.0 (Fig.4). The boundaries of the region 
were determined by recombination events that occurred between markers D10S603 and D10S1727 in individuals 
II:3 and II:1 (Fig.2A), respectively. 
Mutation screening. According to the ENSEMBL and UCSC human genome databases the critical interval 
contains 312 ESTs including 51 known genes, full-length cDNAs and predicted proteins. Likely candidate genes 
were initially selected and screened for mutations but no pathogenic change was found. Sanger sequencing of 
the entire coding region of all 51 genes, splice site junctions, 5’ and 3’ UTR, promoters as well as 5 microRNAs 
(miRNA), 4 miscellaneous RNAs (miscRNA), 1 ribosomal RNA (RRNA), 2 spliceosomal RNAs (SnRNA), 1 small 
nucleolar RNA (SnoRNA) and 1 long non-coding RNA (LincRNA) was subsequently performed but no mutation 
was detected. 
Comparative Genomic Hybridization. The whole genome CNV scan did not reveal large genomic aberrations. 
Also no likely disease-associated alteration was detected in the analysis of chromosome 10 tiling array CGH  
(Fig.5). 
 
INTRODUCTION 
Cone-rod dystrophy (CORD [MIM #120970]) is a group of genetically and phenotypically heterogenous retinal 
disorders characterized by primary degeneration of cone photoreceptors, followed by loss of rod 
photoreceptors (Fig.1). CORD usually manifests in childhood or early adulthood and leads to an early 
reduction in visual acuity and colour vision, photophobia, sometimes fine nystagmus, and central or 
paracentral scotomas. In the second stage, due to secondary rod involvement, night blindness becomes 
apparent, and loss of the visual field extends to the periphery. Genetic heterogeneity of CORD includes 
autosomal dominant (adCORD), autosomal recessive (arCORD), and X-linked (xlCORD) inheritance. To date, 
ten genes (AIPL1, CRX, GUCA1A, GUCY2D, PITPNM3, PROM1, PRPH2, RIMS1, SEMA4A and UNC119) 
and two loci (CORD4 and RCD1) have been identified as responsible for autosomal dominant cone or cone-
rod dystrophy (RetNet).  
Figure 5. Comparative Genomic Hybridization (CGH) array analyses of the 
pedigree. (A) Whole genome 385K tiling array. (B) Chromosome 10 385K 
tiling array. The linked interval is indicated by a red square.  
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